CN Patent

CN119522109A — 用于钙调磷酸酶抑制剂的间歇性给药的组合物

Assigned to Individual · Expires 2025-02-25 · 1y expired

What this patent protects

本文提供了钙调磷酸酶抑制剂和细胞色素p450抑制剂的组合物和给药方案。

USPTO Abstract

本文提供了钙调磷酸酶抑制剂和细胞色素p450抑制剂的组合物和给药方案。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN119522109A
Jurisdiction: CN
Classification: —
Expires: 2025-02-25
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.